MedPath

INFRALINE LIQ

INFRALINE LIQ

Discontinued
DIN Number

00402508

Drug Class

Human

Market Date

Dec 31, 1963

Company
HC

rolmex international inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00402508
AIG Number0303372003
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
M02AC PREPARATIONS WITH SALICYLIC ACID DERIVATIVES
Product Specifications
Dosage FormLiquid
Route of AdministrationTopical
AHFS Classification28:08.04.24
Health Canada Classification

ACTIVE INGREDIENTS (3)

EUCALYPTOLActive
Strength: 633 MG / 30 ML
Monograph: EUCALYPTOL
MENTHOLActive
Strength: 950 MG / 30 ML
Monograph: MENTHOL
METHYL SALICYLATEActive
Strength: 1.9 G / 30 ML
Monograph: METHYL SALICYLATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.